153 related articles for article (PubMed ID: 10194654)
1. Prescribing and emergency admissions for heart failure in greater Glasgow.
Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
5. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
6. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of heart decompensation using angiotensin converting enzyme inhibitors. Pharmaco-economic aspects].
Kulbertus H
Rev Med Liege; 1998 May; 53(5):255-8. PubMed ID: 9689878
[TBL] [Abstract][Full Text] [Related]
8. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
[TBL] [Abstract][Full Text] [Related]
9. Trends in prescribing ACE-inhibitors for congestive heart failure in elderly people.
Antonelli Incalzi R; Pedone C; Pahor M; Onder G; Carbonin PU;
Aging Clin Exp Res; 2002 Dec; 14(6):516-21. PubMed ID: 12674493
[TBL] [Abstract][Full Text] [Related]
10. Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community.
Nielsen OW; McDonagh T; Cowburn P; Blue L; Robb SD; Dargie H
Eur Heart J; 2004 Oct; 25(19):1718-25. PubMed ID: 15451150
[TBL] [Abstract][Full Text] [Related]
11. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group.
Gambassi G; Forman DE; Lapane KL; Mor V; Sgadari A; Lipsitz LA; Bernabei R
Am Heart J; 2000 Jan; 139(1 Pt 1):85-93. PubMed ID: 10618567
[TBL] [Abstract][Full Text] [Related]
12. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
[TBL] [Abstract][Full Text] [Related]
13. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
14. Lack of improvement in outpatient management of congestive heart failure in the United States.
Banerjee D; Stafford RS
Arch Intern Med; 2010 Aug; 170(15):1399-400. PubMed ID: 20696970
[No Abstract] [Full Text] [Related]
15. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center.
McDermott MM; Feinglass J; Lee P; Mehta S; Schmitt B; Lefevre F; Puppala J; Gheorghiade M
Am Heart J; 1997 Nov; 134(5 Pt 1):901-9. PubMed ID: 9398102
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians.
McKee SP; Leslie SJ; LeMaitre JP; Webb DJ; Denvir MA
Eur J Heart Fail; 2003 Aug; 5(4):549-55. PubMed ID: 12921818
[TBL] [Abstract][Full Text] [Related]
17. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Adigun AQ; Ajayi AA
Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.
Weiss R; Buckley K; Clifford T
Clin Ther; 2002 Sep; 24(9):1451-62. PubMed ID: 12380636
[TBL] [Abstract][Full Text] [Related]
19. A four-part regimen for clinical heart failure.
Freudenberger RS; Gottlieb SS; Robinson SW; Fisher ML
Hosp Pract (1995); 1999 Sep; 34(9):51-6, 59-64. PubMed ID: 10901760
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
Crozier I; Ikram H
Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
